Lv11
60 积分 2023-05-29 加入
[Artificial intelligence-based automated assessment of coronary flow reserve from angiography and the impact of different vasodilators]
3小时前
求助中
[Chinese guidelines on diagnosis and management of atrial fibrillation]
8个月前
已完结
[Improve the level of standardized diagnosis and treatment of coronary microvascular disease]
8个月前
已完结
[Chinese guidelines for the diagnosis and management of patients with chronic coronary syndrome]
8个月前
已完结
[Chinese guidelines for the diagnosis and treatment of heart failure 2018]
8个月前
已完结
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
9个月前
已完结
An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerosis
9个月前
已完结
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial
10个月前
已完结
Alternative Treatment Regimens With the PCSK9 Inhibitors Alirocumab and Evolocumab: A Pharmacokinetic and Pharmacodynamic Modeling Approach
11个月前
已完结
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial
11个月前
已关闭
皖公网安备34019202002308
